Actively Recruiting
Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block
Led by Ataturk University · Updated on 2026-05-12
60
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective, randomized, double-blind clinical trial aims to compare the efficacy of two local anesthetic regimens for ultrasound-guided popliteal sciatic nerve block in adult patients undergoing elective distal lower extremity surgery. Eligible participants (ages 18-65, ASA physical status I-III, BMI 18-35 kg/m²) will be randomized into two equal groups of 30. Patients in Group BL will receive a combination of 10 mL 2% lidocaine and 10 mL 0.5% bupivacaine, while patients in Group B will receive 20 mL 0.5% bupivacaine alone, administered via ultrasound-guided popliteal sciatic nerve block prior to surgery. The primary outcome is the onset time of sensory and motor blockade. Secondary outcomes include block success rate, duration of sensory and motor block, postoperative opioid consumption, pain scores assessed by the Numeric Rating Scale (NRS) at 2, 4, 8, 12, and 24 hours postoperatively, Quality of Recovery-15 (QoR-15) score, and incidence of rebound pain. The study is conducted at Ataturk University Research Hospital, Department of Anesthesiology and Reanimation, Erzurum, Turkey.
CONDITIONS
Official Title
Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- American Society of Anesthesiologists (ASA) physical status classification I, II, or III
- Scheduled for elective distal lower extremity surgery (below-knee)
- Body mass index (BMI) between 18 and 35 kg/m8
- Provision of written informed consent
You will not qualify if you...
- Refusal to participate in the study
- Morbid obesity (BMI 235 kg/m8)
- Known allergy or hypersensitivity to any local anesthetic agent
- Severe cardiac, hepatic, or renal disease
- Pre-existing neurological deficits or peripheral neuropathy
- Use of anticoagulant therapy
- History of prior surgery or significant scar tissue in the popliteal fossa
- Pregnancy
- Chronic opioid use at home
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ataturk University
Erzurum, Turkey (Türkiye)
Actively Recruiting
Research Team
A
AHMET MURAT YAYIK, MD, PhD
CONTACT
A
ASLIHAN BOROGLU, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here